Leinco Technologies

Anti-Human HLA-DR Monomorphic - Purified (PhenoCycler-Fusion (CODEX)® Ready)

Product Code:
 
LEI-H500
Product Group:
 
Primary Antibodies
Host Type:
 
Mouse
Antibody Isotype:
 
IgG2a
Antibody Clonality:
 
Monoclonal
Antibody Clone:
 
L243
Regulatory Status:
 
RUO
Target Species:
  • Baboon
  • Canine (dog)
  • Chimpanzee
  • Cynomolgus Monkey
  • Human
  • Marmoset
  • Rhesus Macaque
  • Squirrel monkey
Applications:
  • Immunohistochemistry- Frozen Section (IHC-F)
  • Spatial Biology
Shipping:
 
Ambient
Storage:
 
This antibody is stable for at least one week when stored at 2-8°C. For long term storage aliquot in working volumes without diluting and store at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
 

No additional charges, what you see is what you pay! *

CodeSizePrice
LEI-H500-50ug50 ug£167.00
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: US.
Typical lead time: 14-21 working days.
Contact us for more accurate information.
  • Further Information
  • References
  • Show All

Further Information

Antigen Distribution:
The HLA-DR antigen is present on B-lymphocytes, activated T-lymphocytes and activated natural killer (NK) lymphocytes. This antigen is also expressed on monocytes, macrophages, human progenitor cells and B-cell lymphomas.
Concentration:
0.5 mg/ml
Conjugate/Tag/Label:
Purified (PhenoCycler® Ready)
Format:
This purified antibody is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4.
Formulation:
This purified antibody is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4.
Target:
HLA-DR Monomorphic

References

1. Wright, TM. et al. (2001) Arthritis Rheum. 44(7):1654-9. Article Link 2. Lampson, LA. et al. (1980) J. Immunol. 125:393 3. Yu, D. et al. (1980) J. Exp. Med. 151:91 4. Warnke, R. et al. (1980) N. Eng. J. Med. 303:293 5. Wilkinson, KA. et al. (2005) Infect Immun. 74(5):2991-8